DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
-3.45%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$334M
AUM Growth
+$334M
Cap. Flow
-$2.99M
Cap. Flow %
-0.9%
Top 10 Hldgs %
52.03%
Holding
83
New
4
Increased
23
Reduced
12
Closed
11

Top Buys

1
CYTK icon
Cytokinetics
CYTK
$3.26M
2
IPSC icon
Century Therapeutics
IPSC
$2.89M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$2.51M
4
ATRC icon
AtriCure
ATRC
$2.22M
5
RVMD icon
Revolution Medicines
RVMD
$2.12M

Top Sells

1
FATE icon
Fate Therapeutics
FATE
$5.56M
2
ETNB icon
89bio
ETNB
$4.13M
3
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
$3.65M
4
VKTX icon
Viking Therapeutics
VKTX
$3.37M
5
BHVN icon
Biohaven
BHVN
$2.15M

Sector Composition

1 Healthcare 81.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GNFT
51
Genfit
GNFT
$198M
$812K 0.24%
197,940
– –
MREO
52
Mereo BioPharma
MREO
$275M
$775K 0.23%
1,096,513
– –
SURF
53
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$769K 0.23%
1,100,000
+317,000
+40% +$222K
KPTI icon
54
Karyopharm Therapeutics
KPTI
$61.4M
$750K 0.22%
192,678
– –
SYRS
55
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$710K 0.21%
265,878
– –
SPRB
56
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$690K 0.21%
+312,000
New +$690K
ACRV icon
57
Acrivon Therapeutics
ACRV
$42.2M
$649K 0.19%
51,148
+35,500
+227% +$450K
PRDS
58
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$633K 0.19%
479,386
– –
MASI icon
59
Masimo
MASI
$7.43B
$554K 0.17%
3,000
– –
KNTE
60
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$506K 0.15%
81,008
+10,000
+14% +$62.5K
RGLS
61
DELISTED
Regulus Therapeutics
RGLS
$471K 0.14%
555,555
– –
MDNA
62
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$416K 0.12%
660,000
– –
STRO icon
63
Sutro Biopharma
STRO
$85.6M
$391K 0.12%
+84,700
New +$391K
IMA
64
ImageneBio, Inc. Common Stock
IMA
$153M
$390K 0.12%
112,936
-9,581
-8% -$33.1K
ADAP
65
Adaptimmune Therapeutics
ADAP
$13.9M
$383K 0.11%
351,064
– –
CMPX icon
66
Compass Therapeutics
CMPX
$466M
$382K 0.11%
116,882
-485,169
-81% -$1.59M
NXTC icon
67
NextCure
NXTC
$13.3M
$278K 0.08%
187,696
– –
LCTX icon
68
Lineage Cell Therapeutics
LCTX
$281M
$210K 0.06%
140,000
– –
INGN icon
69
Inogen
INGN
$213M
$187K 0.06%
15,000
– –
SPRO icon
70
Spero Therapeutics
SPRO
$117M
$181K 0.05%
125,000
– –
CGEN icon
71
Compugen
CGEN
$133M
$144K 0.04%
205,202
– –
REUN
72
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$8.7K ﹤0.01%
12,598
-35,081
-74% -$24.2K
PHAS
73
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-321,856
Closed -$9.69K
CINC
74
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-48,000
Closed -$590K
FSTX
75
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-576,881
Closed -$3.65M
1 2
3
4